semaglutide and hyperthyroidism Frontiers Can Semaglutide Cause Thyroid Issues?

This first-of-its kind multi-country research examines the health and economic value of combining GLP-1 therapy with structured exercise.

Podcast powered by Firstory.

Participants Adult patients with diabetes who were newly prescribed add-on non-insulin glucose-lowering agents and were on metformin between 2005-2020

People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, according to a new study.

In February 2026, the FDA publicly announced its intent to take action targeting mass-marketed, non-FDA-approved compounded GLP1 products, emphasizing that promotional claims implying equivalence to FDAapproved drugs can trigger enforcement risk